Logo image of UPC

UNIVERSE PHARMACEUTICALS INC (UPC) Stock Analyst Earnings Estimates

NASDAQ:UPC - Nasdaq - KYG9442G1385 - Common Stock - Currency: USD

3.67  +0.19 (+5.46%)

After market: 3.68 +0.01 (+0.27%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
UPC revenue by date.UPC revenue by date.
40.14M
-16.34%
32.309M
-19.51%
23.025M
-28.74%
EBITDA
YoY % growth
UPC ebitda by date.UPC ebitda by date.
-6.91M
-149.22%
-3.457M
49.97%
-7.534M
-117.92%
EBIT
YoY % growth
UPC ebit by date.UPC ebit by date.
-7.44M
-154.75%
-3.966M
46.69%
-8.02M
-102.21%
Operating Margin
UPC operating margin by date.UPC operating margin by date.
-18.54%-12.28%-34.83%
EPS
YoY % growth
UPC eps by date.UPC eps by date.
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
9.153M
-28.96%
%
Q4 2024
Q2Q % growth
10.14M
-26.74%
%
Q2 2024
Q2Q % growth
12.884M
-30.23%
%
Q4 2023
Q2Q % growth
13.842M
-13.16%
%
Q2 2023
Q2Q % growth
18.467M
-23.69%
%
Q4 2022
Q2Q % growth
15.94M
-66.78%
%
Q2 2022
Q2Q % growth
24.2M
-0.38%
%
Q4 2021
Q2Q % growth
47.98M
56.29%
%
Q2 2021
Q2Q % growth
24.293M
48.22%
%
Q4 2020
Q2Q % growth
30.7M
-7.61%
%
Q2 2020
Q2Q % growth
16.39M
-9.60%
%
UPC Yearly Revenue VS EstimatesUPC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A